Results for tag: "Restless Leg Syndrome Drug"

Restless Leg Syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move one's legs. It is often accompanied by uncomfortable sensations in the legs, such as tingling, burning, or itching. Treatment for RLS typically involves medications that act on the central nervous system (CNS). These drugs are typically dopamine agonists, which work by increasing the amount of dopamine in the brain. Other drugs used to treat RLS include anticonvulsants, opioids, and benzodiazepines. The RLS drug market is a subset of the larger CNS drug market. It is a relatively small market, but is growing due to increased awareness of the disorder and the availability of new treatments. The market is highly competitive, with many companies offering similar products. Some companies in the RLS drug market include GlaxoSmithKline, Pfizer, Merck, Novartis, and Teva Pharmaceuticals. Show Less Read more